Roger Tuen is CEO of Amicoat. Mr. Tuen brings more than 20 years of international life science experience in commercial, business development and general management roles in listed companies. He has negotiated several licensing agreements with multinational and regional companies, and managed strategic alliances and partnerships throughout his carrier. He holds a MSc Pharm from the University of Oslo and a MBA from the Norwegian School of Management and ESCP-EAP, France.